stocks logo

PBH

Prestige Consumer Healthcare Inc
$
74.900
-0.23(-0.306%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
75.380
Open
74.480
VWAP
74.71
Vol
41.89K
Mkt Cap
3.70B
Low
74.480
Amount
3.13M
EV/EBITDA(TTM)
12.17
Total Shares
49.92M
EV
4.62B
EV/OCF(TTM)
18.35
P/S(TTM)
3.31
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q2
FY2026Q1
298.19M
+2.71%
1.260
+3.28%
291.79M
+2.82%
1.192
+9.4%
260.71M
-2.41%
0.993
+10.28%
Estimates Revision
The market is revising Downward the revenue expectations for Prestige Consumer Healthcare Inc. (PBH) for FY2026, with the revenue forecasts being adjusted by -0.48% over the past three months. During the same period, the stock price has changed by -8.91%.
Revenue Estimates for FY2026
Revise Downward
down Image
-0.48%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
down Image
-0.19%
In Past 3 Month
Stock Price
Go Down
down Image
-8.91%
In Past 3 Month
2 Analyst Rating
up Image
13.48% Upside
Wall Street analysts forecast PBH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PBH is 85.00 USD with a low forecast of 85.00 USD and a high forecast of 85.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
up Image
13.48% Upside
Current: 74.900
sliders
Low
85.00
Averages
85.00
High
85.00
RBC Capital
Ryland Conrad
Hold
Maintains
$96 → $97
2025-03-21
Reason
Oppenheimer
Rupesh Parikh
Buy
Maintains
$87 → $93
2025-02-13
Reason
Oppenheimer raised the firm's price target on Prestige Consumer to $93 from $87 and keeps an Outperform rating on the shares after meetings with senior management. The company does not comment on intra-quarter business trends. Overall, the firm walked away still confident with its bullish view and longer-term thesis. The tone of management remained constructive on the company's shorter- and longer-term prospects.
DA Davidson
Linda Bolton Weiser
Strong Buy
Maintains
$95 → $104
2025-02-07
Reason
Canaccord Genuity
Susan Anderson
Strong Buy
Maintains
$93 → $100
2025-02-07
Reason
DA Davidson
Linda Bolton Weiser
Strong Buy
Maintains
$95
2024-11-11
Reason
Jefferies
Stephanie Wissink
Strong Buy
to
Hold
Initiates
$70 → $76
2024-09-24
Reason

Valuation Metrics

The current forward P/E ratio for Prestige Consumer Healthcare Inc (PBH.N) is 15.63, compared to its 5-year average forward P/E of 14.21. For a more detailed relative valuation and DCF analysis to assess Prestige Consumer Healthcare Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
14.21
Current PE
15.63
Overvalued PE
16.01
Undervalued PE
12.40

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
11.57
Current EV/EBITDA
12.30
Overvalued EV/EBITDA
12.45
Undervalued EV/EBITDA
10.69

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average PS
2.70
Current PS
3.26
Overvalued PS
3.16
Undervalued PS
2.24

Financials

Annual
Quarterly
FY2025Q4
YoY :
+7.05%
296.52M
Total Revenue
FY2025Q4
YoY :
+22.81%
100.89M
Operating Profit
FY2025Q4
YoY :
+1.35%
50.13M
Net Income after Tax
FY2025Q4
YoY :
+2.04%
1.00
EPS - Diluted
FY2025Q4
YoY :
-8.46%
58.37M
Free Cash Flow
FY2025Q4
YoY :
+5.44%
55.63
Gross Profit Margin - %
FY2025Q4
YoY :
+0.52%
21.38
FCF Margin - %
FY2025Q4
YoY :
-5.32%
16.91
Net Margin - %
FY2025Q4
YoY :
-4.61%
8.90
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
688.7K
USD
2
6-9
Months
959.3K
USD
1
0-12
Months
12.0M
USD
6
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 622.44% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
2
132.8K
Volume
Months
6-9
2
18.4K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

PBH News & Events

Events Timeline

2025-06-17 (ET)
2025-06-17
17:42:58
Medtech recalls Little Remedies Honey Cough Syrup due to contamination
select
2025-05-08 (ET)
2025-05-08
06:13:27
Prestige Consumer sees FY26 EPS $4.70-$4.82, consensus $4.79
select
2025-05-08
06:12:24
Prestige Consumer reports Q4 EPS $1.32, consensus $1.29
select
Sign Up For More Events

News

2.0
07-25NASDAQ.COM
RSI Alert: Prestige Consumer Healthcare (PBH) Now Oversold
7.0
06-19NASDAQ.COM
Medtech Products Recalls Little Remedies Honey Cough Syrup
7.0
06-17Newsfilter
Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination
Sign Up For More News

FAQ

arrow icon

What is Prestige Consumer Healthcare Inc (PBH) stock price today?

The current price of PBH is 74.9 USD — it has decreased -0.31 % in the last trading day.

arrow icon

What is Prestige Consumer Healthcare Inc (PBH)'s business?

arrow icon

What is the price predicton of PBH Stock?

arrow icon

What is Prestige Consumer Healthcare Inc (PBH)'s revenue for the last quarter?

arrow icon

What is Prestige Consumer Healthcare Inc (PBH)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Prestige Consumer Healthcare Inc (PBH)'s fundamentals?

arrow icon

How many employees does Prestige Consumer Healthcare Inc (PBH). have?

arrow icon

What is Prestige Consumer Healthcare Inc (PBH) market cap?